Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Hold
0
-$2.12K 927
2023
Q1
Hold
0
871
2022
Q1
Sell
-2
Closed -$6K 986
2021
Q4
$6K Buy
+2
New +$438 ﹤0.01% 872

Other funds holding ZTS

Moors & Cabot's ZTS Position: Q2 2026 in Review

Moors & Cabot reduced its Zoetis (ZTS) stake by 8.2% in Q2 2026, selling an estimated $102K and leaving 12,106 shares worth $870K. The position accounts for 0.03% of the portfolio, ranked #425.

Moors & Cabot first reported a position in ZTS in Q1 2014 and has held it in 50 quarters since. The position peaked at $4.48M in Q4 2021. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Moors & Cabot held 12,106 shares of Zoetis worth $870K as of Q2 2026.
  • Moors & Cabot sold 1,084 Zoetis shares in Q2 2026, an estimated $102K.
  • Zoetis made up 0.03% of Moors & Cabot's portfolio in Q2 2026, its #425 holding.
  • Moors & Cabot first reported a position in Zoetis in Q1 2014 and has held it in 50 quarters since.
  • Moors & Cabot's Zoetis position peaked at $4.48M in Q4 2021.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.